Scans compared for children with neuroblastoma
Part of Cancer clinical trials.
This trial compares two different nuclear medicine scans to see which one best shows where neuroblastoma is in a child’s body. The results may help doctors choose the most helpful scan for planning care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child has been diagnosed with neuroblastoma from tissue testing, or doctors strongly suspect it based on exam, scans, labs, and gene tests
- Your child has had (or will have) an mIBG scan within 7 days of an FB G PET/CT scan
- No cancer treatment happens between the first scan and the second scan
- A parent or legal guardian can understand the study and sign the consent form
- Your child is not pregnant (if applicable)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new PET scan tracer (18F-MFBG) against the standard SPECT scan (123I-MIBG) to see if it better shows neuroblastoma tumors. It's for children whose cancer has come back or hasn't responded to treatment.
This trial uses a special PET scan called 18F-mFBG to take pictures of neuroblastoma tumors. It helps doctors see where the cancer is and whether treatment is working.
This early-phase trial uses a special PET/CT scan to help evaluate neural crest tumors, which include conditions like neuroblastoma. It may help doctors understand how well the scan shows tumor activity to guide diagnosis and treatment planning.
This trial uses special PET/CT or SPECT/CT scans that light up certain types of tumor cells (neuroblastoma and pheochromocytoma/paraganglioma). The scans help doctors see where the cancer is, how far it has spread, and whether treatment is working.
This study tests how well a new PET/CT scan using 68Ga-DOTATATE can find neuroblastoma. It’s for children and young adults who are being planned for a different scan (123I-MIBG) to compare imaging results.
This study is for children or young adults already in specific brain tumor or neuroblastoma trials. It looks at how a type of imaging (MCT) might help doctors better understand and treat these cancers.
Hear when a new Neuroblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.